+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Microphysiological System Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6145477
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Microphysiological System Market is projected to reach USD 190.72 Million in 2026. It is expected to continue growing at a CAGR of 17.18%, reaching USD 498.01 Million by 2032.

Microphysiological Systems: Executive Overview

Microphysiological systems (MPS) are engineered in vitro platforms that reproduce selected structural, mechanical, biochemical, and functional features of human tissues or organs. Often described as organ-on-chip or tissue-on-chip systems, they combine human cells, biomaterials, microfluidics, sensors, and computational analysis to support research, safety assessment, and translational development. Their value lies in generating human-relevant evidence while reducing dependence on conventional two-dimensional cultures and selected animal studies. Adoption remains shaped by biological reproducibility, protocol standardization, validation requirements, regulatory acceptance, workflow integration, and the availability of specialized expertise.

From Static Cell Models to Human-Relevant Experimental Platforms

The field is shifting from isolated proof-of-concept devices toward more reproducible platforms designed for repeatable use across research and development workflows. Important changes include greater use of primary and stem-cell-derived human cells, multicellular co-culture, perfused tissue models, integrated sensing, and linked organ systems. Researchers are also placing greater emphasis on standardized operating procedures, reference materials, interlaboratory comparison, and transparent reporting of model limitations. These developments are helping position MPS as complementary tools for target validation, toxicity assessment, disease modeling, pharmacology, and personalized research rather than as standalone replacements for every existing method.

Artificial Intelligence Strengthens Model Design, Interpretation, and Quality Control

Artificial intelligence is influencing MPS through image analysis, time-series interpretation, experimental optimization, and prediction of tissue responses. Machine-learning methods can help quantify morphology, barrier integrity, contractility, electrophysiology, metabolic activity, and other phenotypic signals that are difficult to evaluate consistently by manual review. Digital-twin concepts and mechanistic models may further support integration of data from multiple tissues and experimental conditions. However, useful deployment depends on well-annotated datasets, consistent assay procedures, explainable outputs, protection against batch effects, and independent validation. AI can accelerate analysis and improve reproducibility, but it does not remove the need for biological controls, domain expertise, or regulatory scrutiny.

Regional Insights: Regulation, Infrastructure, and Translation Shape Adoption

North America combines strong biomedical research capacity, biotechnology activity, and interest in alternative testing approaches, while implementation is influenced by validation and regulatory expectations. Europe benefits from coordinated research networks, advanced life-science infrastructure, and policy attention to non-animal methods, with cross-border standardization remaining important. Asia-Pacific shows diverse development across Australia, China, India, Japan, and South Korea, supported by advanced manufacturing, pharmaceutical research, and public-sector science programs. Latin America, including Brazil and Mexico, is developing capabilities through academic, pharmaceutical, and translational partnerships, although access to specialized equipment and funding can vary. The Middle East is building research and innovation capacity in selected hubs, while Africa presents opportunities for locally relevant disease models and collaborative development alongside constraints related to infrastructure, training, and procurement.

Group Insights: Collaboration Networks Accelerate Standardization

ASEAN economies can benefit from shared protocols, regional training, and collaborative biobanking that reduce duplication across developing MPS programs. BRICS members offer substantial scientific and clinical diversity, making joint validation studies and locally relevant disease models particularly valuable. The European Union provides a framework for coordinated research, harmonized documentation, and regulatory dialogue across member states. G7 countries contribute mature biomedical ecosystems, advanced instrumentation, and policy engagement, but continued alignment is needed to make evidence portable between jurisdictions. GCC members can support adoption through centralized research facilities, translational investment, and partnerships with international institutions. NATO countries, viewed as a research and technology network rather than a single regulatory market, may gain from interoperable standards and shared expertise in biosafety, resilience, and advanced biomedical engineering.

Country Insights: Diverse Capabilities Create Complementary Roles

The United States and Canada have established strengths in biomedical engineering, drug development, and translational research. The United Kingdom, Germany, France, Italy, and Spain contribute through university-led innovation, pharmaceutical research, and European collaborative programs, with harmonized validation remaining a priority. Japan and South Korea combine advanced electronics, materials science, and life-science capabilities, supporting sensor integration and automated platforms. China is expanding research and manufacturing capacity across microfluidics, cell biology, and pharmaceutical applications. India is developing MPS expertise through academic, biotechnology, and pharmaceutical collaborations, while Australia contributes strong biomedical research and translational science. Brazil and Mexico are important Latin American contributors, with opportunities to connect academic capability to industrial validation. Russia maintains relevant scientific expertise, although international collaboration, access to equipment, and regulatory connectivity can affect deployment.

Industry Priorities: Build Validated, Interoperable, and Decision-Ready Platforms

Industry leaders should prioritize clearly defined use cases and select model complexity according to the decision being supported. Establishing standardized protocols, acceptance criteria, quality controls, and documented performance characteristics is essential before scaling deployment. Organizations should create multidisciplinary teams spanning biology, engineering, data science, toxicology, pharmacology, and regulatory affairs. Partnerships with academic centers, contract research organizations, technology developers, and public agencies can improve validation and reduce implementation risk. Leaders should also invest in interoperable data systems, AI governance, staff training, and evidence packages that connect MPS outputs with established clinical, preclinical, and regulatory endpoints. A staged approach-pilot, reproduce, benchmark, then integrate-offers a practical path to responsible adoption.

Research Methodology: Evidence-Based Synthesis of the MPS Landscape

This executive summary is based on a structured review of the microphysiological systems field, organized around technology development, applications, enabling infrastructure, regulation, artificial intelligence, and geographic adoption conditions. Evidence should be assessed using peer-reviewed studies, regulatory and standards publications, government or intergovernmental materials, validated technical documentation, and relevant clinical or translational research records. Findings are interpreted comparatively across the specified regions, country groups, and countries, with attention to differences in scientific capacity, funding, manufacturing, policy, and implementation readiness. Because platform performance can vary by tissue type, cell source, device architecture, and assay endpoint, conclusions should distinguish demonstrated capabilities from emerging possibilities and avoid treating all MPS formats as interchangeable.

Conclusion: Translation Depends on Trustworthy Evidence and Practical Integration

Microphysiological systems are becoming important tools for producing more human-relevant biological evidence across research, safety, and therapeutic development. Their long-term contribution will depend less on novelty alone than on reproducibility, standardization, transparent validation, and compatibility with existing decision processes. Regional and country-level strengths are complementary, creating opportunities for shared protocols, cross-border benchmarking, and responsible data integration. Artificial intelligence can extend the usefulness of MPS, provided that data quality, interpretability, and biological validation remain central. Organizations that focus on clearly defined applications and decision-ready evidence will be best positioned to convert technological progress into reliable scientific and operational value.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Microphysiological System Market, by Technology
7.1. Introduction
7.2. Organ On Chip
7.3. Organoids
7.4. Microfluidics
7.5. 3D Bioprinting
7.6. Spheroids
8. Microphysiological System Market, by System Type
8.1. Introduction
8.2. Single-organ models
8.3. Multi-organ (body-on-a-chip) systems
9. Microphysiological System Market, by Research Model
9.1. Introduction
9.2. Human cell-based MPS
9.3. Animal cell-based MPS
9.4. Stem cell (iPSC) based models
9.5. Hybrid/organotypic models
10. Microphysiological System Market, by Offering
10.1. Introduction
10.2. System/Solution
10.3. Services
10.4. Consumables
11. Microphysiological System Market, by Application
11.1. Introduction
11.2. Drug discovery & screening
11.3. Disease modeling
11.4. Toxicology & safety assessment
11.5. Personalized medicine
11.6. Regulatory testing
11.7. Bioavailability & efficacy studies
12. Microphysiological System Market, by End User
12.1. Introduction
12.2. Pharmaceutical & biotechnology companies
12.3. Academic & research institutes
12.4. Contract Research Organizations (CROs)
12.5. Government & regulatory agencies
12.6. Hospitals & clinical research centers
13. Microphysiological System Market, by Deployment Mode
13.1. Introduction
13.2. In-house lab installations
13.3. Outsourced MPS services
14. Microphysiological System Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. Europe
14.4. North America
14.5. Latin America
14.6. Africa
14.7. Middle East
15. Microphysiological System Market, by Group
15.1. Introduction
15.2. NATO
15.3. G7
15.4. European Union
15.5. BRICS
15.6. ASEAN
15.7. GCC
16. Microphysiological System Market, by Country
16.1. Introduction
16.2. United States
16.3. China
16.4. Germany
16.5. Japan
16.6. India
16.7. United Kingdom
16.8. France
16.9. Canada
16.10. Italy
16.11. Australia
16.12. Brazil
16.13. South Korea
16.14. Mexico
16.15. Russia
16.16. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Emulate, Inc.
18.2. CN Bio Innovations Ltd.
18.3. InSphero AG
18.4. TissUse GmbH
18.5. MIMETAS BV
18.6. Hesperos, Inc.
18.7. SynVivo, Inc.
18.8. Cherry Biotech SAS
18.9. BioIVT LLC
18.10. Kirkstall Ltd.
18.11. AIM Biotech Pte. Ltd.
18.12. Altis Biosystems, Inc.
18.13. AlveoliX AG
18.14. Ananda Devices
18.15. Beijing Daxiang Biotech Co., Ltd
18.16. BI/OND Solutions B.V.
18.17. BiomimX S.r.l.
18.18. FUJIFILM Cellular Dynamics
18.19. ImmuONE
18.20. Netri, Inc.
18.21. Obatala Sciences, Inc.
18.22. Quris Technologies LTD
18.23. React4life S.p.A.
18.24. Valo Health, Inc.
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Microphysiological System Market, Years Considered for the Study
FIGURE 2. Global Microphysiological System Market, Research Design
FIGURE 3. Global Microphysiological System Market, Research Framework
FIGURE 4. Global Microphysiological System Market, Data Triangulation
FIGURE 5. Global Microphysiological System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Microphysiological System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Microphysiological System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Microphysiological System Market Size, by System Type, 2025 vs 2032 (%)
FIGURE 9. Global Microphysiological System Market Size, by System Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Microphysiological System Market Size, by Research Model, 2025 vs 2032 (%)
FIGURE 11. Global Microphysiological System Market Size, by Research Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Microphysiological System Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 13. Global Microphysiological System Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Microphysiological System Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Microphysiological System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Microphysiological System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Microphysiological System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Microphysiological System Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 19. Global Microphysiological System Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Microphysiological System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Microphysiological System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Microphysiological System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Microphysiological System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Microphysiological System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Microphysiological System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Microphysiological System Market Segmentation & Coverage
TABLE 2. Global Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Organ On Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Organ On Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Organ On Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Organoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Organoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Organoids Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global 3D Bioprinting Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global 3D Bioprinting Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global 3D Bioprinting Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Spheroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Spheroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Spheroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 20. Global Single-organ models Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Single-organ models Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Single-organ models Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Multi-organ (body-on-a-chip) systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Multi-organ (body-on-a-chip) systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Multi-organ (body-on-a-chip) systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 27. Global Human cell-based MPS Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Human cell-based MPS Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Human cell-based MPS Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Animal cell-based MPS Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Animal cell-based MPS Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Animal cell-based MPS Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Stem cell (iPSC) based models Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Stem cell (iPSC) based models Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Stem cell (iPSC) based models Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Hybrid/organotypic models Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hybrid/organotypic models Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hybrid/organotypic models Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 40. Global System/Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global System/Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global System/Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 50. Global Drug discovery & screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Drug discovery & screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Drug discovery & screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Disease modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Disease modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Disease modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Toxicology & safety assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Toxicology & safety assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Toxicology & safety assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Personalized medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Personalized medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Personalized medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Regulatory testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Regulatory testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Regulatory testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Bioavailability & efficacy studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Bioavailability & efficacy studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Bioavailability & efficacy studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Global Pharmaceutical & biotechnology companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Pharmaceutical & biotechnology companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Pharmaceutical & biotechnology companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Academic & research institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Academic & research institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Academic & research institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Contract Research Organizations (CROs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Contract Research Organizations (CROs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Contract Research Organizations (CROs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Government & regulatory agencies Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Government & regulatory agencies Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Government & regulatory agencies Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Hospitals & clinical research centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Hospitals & clinical research centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Hospitals & clinical research centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 85. Global In-house lab installations Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global In-house lab installations Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global In-house lab installations Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Outsourced MPS services Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Outsourced MPS services Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Outsourced MPS services Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 100. Europe Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Europe Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Europe Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 103. Europe Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 104. Europe Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 105. Europe Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Europe Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Europe Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 108. North America Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. North America Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. North America Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 111. North America Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 112. North America Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 113. North America Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. North America Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. North America Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 116. Latin America Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Latin America Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. Latin America Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 119. Latin America Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 120. Latin America Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 121. Latin America Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Latin America Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Latin America Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 124. Africa Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Africa Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 126. Africa Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 127. Africa Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 128. Africa Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 129. Africa Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Africa Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Africa Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 132. Middle East Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Middle East Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 134. Middle East Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 135. Middle East Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 136. Middle East Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 137. Middle East Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Middle East Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Middle East Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 140. Global Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. NATO Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. NATO Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. NATO Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 144. NATO Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 145. NATO Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 146. NATO Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. NATO Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. NATO Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 149. G7 Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. G7 Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. G7 Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 152. G7 Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 153. G7 Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 154. G7 Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. G7 Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. G7 Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 157. European Union Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. European Union Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. European Union Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 160. European Union Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 161. European Union Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 162. European Union Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. European Union Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. European Union Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 165. BRICS Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. BRICS Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. BRICS Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 168. BRICS Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 169. BRICS Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 170. BRICS Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. BRICS Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. BRICS Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 173. ASEAN Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. ASEAN Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. ASEAN Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 176. ASEAN Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 177. ASEAN Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 178. ASEAN Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. ASEAN Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. ASEAN Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 181. GCC Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. GCC Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 183. GCC Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 184. GCC Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 185. GCC Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 186. GCC Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. GCC Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. GCC Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 189. Global Microphysiological System Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. United States Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 191. United States Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. United States Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 193. United States Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 194. United States Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 195. United States Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. United States Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. United States Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 198. China Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 199. China Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. China Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 201. China Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 202. China Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 203. China Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. China Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. China Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 206. Germany Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 207. Germany Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Germany Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 209. Germany Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 210. Germany Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 211. Germany Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Germany Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Germany Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 214. Japan Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 215. Japan Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. Japan Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 217. Japan Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 218. Japan Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 219. Japan Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Japan Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Japan Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 222. India Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 223. India Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. India Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 225. India Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 226. India Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 227. India Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. India Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. India Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 230. United Kingdom Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 231. United Kingdom Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. United Kingdom Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 233. United Kingdom Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 234. United Kingdom Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 235. United Kingdom Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. United Kingdom Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. United Kingdom Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 238. France Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 239. France Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 240. France Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 241. France Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 242. France Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 243. France Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. France Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. France Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 246. Canada Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 247. Canada Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. Canada Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 249. Canada Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 250. Canada Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 251. Canada Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Canada Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Canada Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 254. Italy Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 255. Italy Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. Italy Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 257. Italy Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 258. Italy Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 259. Italy Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Italy Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Italy Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 262. Australia Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 263. Australia Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. Australia Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 265. Australia Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 266. Australia Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 267. Australia Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Australia Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Australia Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 270. Brazil Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 271. Brazil Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. Brazil Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 273. Brazil Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 274. Brazil Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 275. Brazil Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. Brazil Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Brazil Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 278. South Korea Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 279. South Korea Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. South Korea Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 281. South Korea Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 282. South Korea Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 283. South Korea Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. South Korea Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. South Korea Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 286. Mexico Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 287. Mexico Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. Mexico Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 289. Mexico Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 290. Mexico Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 291. Mexico Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Mexico Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. Mexico Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 294. Russia Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 295. Russia Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. Russia Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 297. Russia Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 298. Russia Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 299. Russia Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Russia Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Russia Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 302. Spain Microphysiological System Market Size, 2017-2032 (USD Million)
TABLE 303. Spain Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 304. Spain Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
TABLE 305. Spain Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
TABLE 306. Spain Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
TABLE 307. Spain Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. Spain Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Spain Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 310. Global Microphysiological System Market Share, by Key Player, 2025
TABLE 311. Global Microphysiological System Market, Key Experts

Companies Mentioned

  • Emulate, Inc.
  • CN Bio Innovations Ltd.
  • InSphero AG
  • TissUse GmbH
  • MIMETAS BV
  • Hesperos, Inc.
  • SynVivo, Inc.
  • Cherry Biotech SAS
  • BioIVT LLC
  • Kirkstall Ltd.
  • AIM Biotech Pte. Ltd.
  • Altis Biosystems, Inc.
  • AlveoliX AG
  • Ananda Devices
  • Beijing Daxiang Biotech Co., Ltd
  • BI/OND Solutions B.V.
  • BiomimX S.r.l.
  • FUJIFILM Cellular Dynamics
  • ImmuONE
  • Netri, Inc.
  • Obatala Sciences, Inc.
  • Quris Technologies LTD
  • React4life S.p.A.
  • Valo Health, Inc.